Publication Name	World Journal of Hepatology
Manuscript ID	17147
Country	Japan

Received	2015-02-21 19:48
Peer-Review Started	2015-02-22 19:13
To Make the First Decision	2015-04-27 15:32
Return for Revision	2015-04-30 09:34
Revised	2015-05-02 23:07
Second Decision	2015-05-29 15:27
Accepted by Journal Editor-in-Chief	2015-05-30 15:26
Accepted by Company Editor-in-Chief	2015-06-08 16:03
Articles in Press	2015-06-08 16:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-13 09:32
Publish the Manuscript Online	2015-08-08 13:55

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Current management of patients with hepatocellular carcinoma
Manuscript Source	Invited Manuscript
All Author List	Tatsuo Kanda, Sadahisa Ogasawara, Tetsuhiro Chiba, Yuki Haga, Masao Omata and Osamu Yokosuka
Funding Agency and Grant Number
Corresponding Author	Tatsuo Kanda, MD, PhD, Associate Professor, Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8677, Japan. kandat-cib@umin.ac.jp
Key Words	Hepatocellular carcinoma; Living donor liver transplantation; Radiofrequency ablation; Surgical resection
Core Tip	Liver transplantation is the first-line treatment of hepatocellular carcinoma (HCC). Surgical resection and radiofrequency ablation (RFA) are second-line HCC treatments. Surgical resection and RFA should only be considered for selected cases. Sorafenib administration, transarterial chemoembolization, stereotactic body radiation treatments, or proton or carbon ion treatments are available as salvage treatments for HCC. Laparoscopic liver resection appears to offer at least a short-term benefit in selected HCC patients. These HCC treatments should be carefully selected or combined in clinical practice.
Publish Date	2015-08-08 13:55
Citation	Kanda T, Ogasawara S, Chiba T, Haga Y, Omata M, Yokosuka O. Current management of patients with hepatocellular carcinoma. World J Hepatol 2015; 7(15): 1913-1920
URL	http://www.wjgnet.com/1948-5182/full/v7/i15/1913.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i15.1913

Full Article (PDF)	WJH-7-1913.pdf
Full Article (Word)	WJH-7-1913.doc
Manuscript File	17147-Review.docx
Answering Reviewers	17147-Answering reviewers.pdf
Audio Core Tip	17147-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	17147-Conflict-of-interest statement.pdf
Copyright License Agreement	17147-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	17147-Language certificate.pdf
Supplementary Material	Supplementary_Material_20150220144026.doc
Peer-review Report	17147-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	17147-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	17147-Scientific misconduct check.pdf
Scientific Editor Work List	17147-Scientific editor work list.pdf